RxDoctor Payments Data

Desire Green, NP

Family · Clarksville, INNPI 1720475395

Payments from drug & device makers

$188in general payments, 2019–2025

Across 5 payments — averaging $37.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$116
  • Gilead$23
  • AstraZeneca$19
  • Merck$16
  • Solventum Corporation$14

What the payments were for

  • Food & beverage$188100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organogenesis Inc.1$116
Gilead1$23
AstraZeneca1$19
Merck1$16
Solventum Corporation1$14

How this compares

$188 in reported general payments places this provider in the 35th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$867,330
Medicare patients
464
Services billed
2,677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Clarksville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →